April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
The involvement of heparin-binding epidermal growth factor like growth factor (HB-EGF) on choroidal neovascularization
Author Affiliations & Notes
  • Yuki Inoue
    Dept of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan
  • Yuhei Hashimoto
    Dept of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan
  • Shinsuke Takata
    Dept of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan
  • Kazuhiro Tsuruma
    Dept of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan
  • Masamitsu Shimazawa
    Dept of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan
  • Hideaki Hara
    Dept of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan
  • Footnotes
    Commercial Relationships Yuki Inoue, None; Yuhei Hashimoto, None; Shinsuke Takata, None; Kazuhiro Tsuruma, None; Masamitsu Shimazawa, None; Hideaki Hara, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 620. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yuki Inoue, Yuhei Hashimoto, Shinsuke Takata, Kazuhiro Tsuruma, Masamitsu Shimazawa, Hideaki Hara; The involvement of heparin-binding epidermal growth factor like growth factor (HB-EGF) on choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 2014;55(13):620.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Although heparin-binding epidermal growth factor-like growth factor (HB-EGF) has been reported to play an essential role in cancer and angiogenesis, its role in the ocular angiogenesis especially choroidal neovascularization (CNV) has not been elucidated. Here, we evaluated the role of HB-EGF in ocular angiogenesis after laser-induced choroidal neovascularization (CNV) using HB-EGF knockout (KO) mice.

Methods: We used conditional HB-EGF KO mice lacking in retina and forebrain to examine the role of HB-EGF after laser-induced CNV model. To investigate the expression of HB-EGF and vascular endothelial growth factor (VEGF), we performed Western blot analysis. In an in vitro study, we used human retinal microvascular endothelial cells (HRMECs) to investigate HB-EGF-induced cell proliferation and migration. Moreover, we used CRM-197, an inhibitor of HB-EGF to evaluate the involvement of HB-EGF on cell proliferation and migration in HRMECs.

Results: In HB-EGF KO mice, CNV area was decreased compared with that in WT mice. The reduction rate was about 27%. Moreover, in retinal pigment epithelium (RPE)-choroidal HB-EGF was increased approximately 2.1-hold (versus the control group) at 3 days after laser-induced CNV, and also the expression of VEGF was upregulated from 5 days onwards after laser-induced CNV. HB-EGF or VEGF increased cell proliferation and migration in HRMECs, and combined application of VEGF with HB-EGF enhanced cell proliferation and migration compared with that of VEGF alone. CRM-197 decreased the HB-EGF- and VEGF-induced cell proliferation and migration.

Conclusions: These findings suggest that HB-EGF plays a pivotal role in CNV. It therefore warrants investigation as a potential therapeutic target for such laser-induced CNV as exudative age-related macular degeneration.

Keywords: 412 age-related macular degeneration • 453 choroid: neovascularization  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×